Renalytix to Present at H.C. Wainwright 24th Annual Global Investment Conference
September 08 2022 - 7:00AM
Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the
company will participate in a fireside chat at the H.C. Wainwright
24th Annual Global Investment Conference to be held September
12-14, 2022. Interested parties may access a live and archived
webcast of the presentation on the “Investors” section of the
Company’s website at https://investors.renalytix.com beginning at
7:00 a.m. Eastern Time on September 12, 2022.
About RenalytixRenalytix
(NASDAQ: RNLX) (LSE: RENX) is an in-vitro diagnostics and
laboratory services company that is the global founder and leader
in the new field of bioprognosis™ for kidney health. The
leadership team, with a combined 200+ years of healthcare and
in-vitro diagnostic experience, has designed its KidneyIntelX
laboratory-developed test to enable risk assessment for rapid
progressive decline in kidney function in adult patients with T2D
with early CKD stages 1-3. We believe that by understanding how
disease will progress, patients and providers can take action early
to improve outcomes and reduce overall health system costs. For
more information, visit www.renalytix.com.
For further information, please contact:
Renalytix plc |
www.renalytix.com |
James McCullough, CEO |
Via Walbrook PR |
|
|
Stifel (Nominated Adviser, Joint Broker) |
Tel: 020 7710 7600 |
Alex Price / Nicholas Moore |
|
|
|
Investec Bank plc (Joint Broker) |
Tel: 020 7597 4000 |
Gary Clarence / Daniel Adams |
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780
or renalytix@walbrookpr.com |
Paul McManus / Lianne Applegarth / Alice Woodings |
Mob: 07980 541 893 / 07584 391 303 / 07407 804 654 |
|
|
CapComm Partners |
Tel: 415-389-6400 or investors@renalytix.com |
Peter DeNardo |
|
Renalytix (NASDAQ:RNLX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Renalytix (NASDAQ:RNLX)
Historical Stock Chart
From Sep 2023 to Sep 2024